期刊
CLINICAL TRANSPLANTATION
卷 32, 期 7, 页码 -出版社
WILEY
DOI: 10.1111/ctr.13277
关键词
financial support; kidney transplantation; living donor
资金
- U.S. Department of Health and Human Services, Health Resources and Services Administration's Division of Transplantation (HRSA/DoT) [U13HS030586]
- [U13 HS07689-09-01]
BackgroundThe National Living Donor Assistance Center (NLDAC) enables living donor kidney transplants through financial assistance of living donors, but its return on investment (ROI) through savings on dialysis costs remains unknown. MethodsWe retrospectively reviewed 2012-2015 data from NLDAC, the United States Renal Data System, and the Scientific Registry of Transplant Recipients to construct 1-, 3-, and 5-year ROI models based on NLDAC applications and national dialysis and transplant cost data. ROI was defined as state-specific federal dialysis cost minus (NLDAC program costs plus state-specific transplant cost), adjusted for median waiting time (WT). ResultsA total of 2425 NLDAC applications were approved, and NLDAC costs were USD $6.76 million. Median donor age was 41years, 66.1% were female, and median income was $33759; 43.6% were evaluated at centers with WT >72months. Median dialysis cost/patient-year was $81485 (IQR $74489-$89802). Median kidney transplant cost/patient-year was $30101 (IQR $26832-$33916). Overall, ROI varied from 5.1-fold (1-year) to 28.2-fold (5-year), resulting in $256 million in savings. Higher ROI was significantly associated with high WT, larger dialysis and transplant costs differences, and more NLDAC applicants completing the donation process. ConclusionsFinancial support for donor out-of-pocket expenses produces dramatic federal savings through incremental living donor kidney transplants.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据